Pharmacogenetics of Membrane Transporters: An Update on Current Approaches

被引:96
作者
Sissung, Tristan M. [2 ]
Baum, Caitlin E. [1 ]
Kirkland, C. Tyler [1 ]
Gao, Rui [1 ]
Gardner, Erin R. [3 ]
Figg, William D. [1 ,2 ]
机构
[1] NCI, Mol Pharmacol Sect, Med Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA
[2] NCI, Clin Pharmacol Program, Med Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA
[3] NCI, Clin Pharmacol Program, SAIC Frederick, Frederick, MD 21702 USA
基金
美国国家卫生研究院;
关键词
ABCB1; ABCC1; ABCC2; ABCG2; OATP1B3; OATP1B1; Pharmacogenetics; Membrane transporters; SINGLE NUCLEOTIDE POLYMORPHISMS; CANCER RESISTANCE PROTEIN; HUMAN MDR1 GENE; OATP1B1; OATP-C; P-GLYCOPROTEIN; ORGANIC ANION; IN-VITRO; ORAL BIOAVAILABILITY; FUNCTIONAL-CHARACTERIZATION; MULTIDRUG TRANSPORTERS;
D O I
10.1007/s12033-009-9220-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This review provides an overview of the pharmacogenetics of membrane transporters including selected ABC transporters (ABCB1, ABCC1, ABCC2, and ABCG2) and OATPs (OATP1B1 and OATP1B3). Membrane transporters are heavily involved in drug clearance and alters drug disposition by actively transporting substrate drugs between organs and tissues. As such, polymorphisms in the genes encoding these proteins may have significant effects on the absorption, distribution, metabolism and excretion of compounds, and may alter pharmacodynamics of many agents. This review discusses the techniques used to identify substrates and inhibitors of these proteins and subsequently to assess the effect of genetic mutation on transport, both in vitro and in vivo. A comprehensive list of substrates for the major drug transporters is included. Finally, studies linking transporter genotype with clinical outcomes are discussed.
引用
收藏
页码:152 / 167
页数:16
相关论文
共 50 条
[21]   Pharmacogenetics in Psychiatry: An Update on Clinical Usability [J].
van Schaik, Ron H. N. ;
Muller, Daniel J. ;
Serretti, Alessandro ;
Ingelman-Sundberg, Magnus .
FRONTIERS IN PHARMACOLOGY, 2020, 11
[22]   Pharmacogenetics of therapies in rheumatoid arthritis: An update [J].
Babiker-Mohamed, Mohamed H. ;
Bhandari, Sambhawana ;
Ranganathan, Prabha .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2024, 38 (04)
[23]   Pharmacogenetics of antidepressant response: an update. [J].
Drago A. ;
De Ronchi D. ;
Serretti A. .
Human Genomics, 3 (3) :257-274
[24]   Pharmacogenetics Update on Biologic Therapy in Psoriasis [J].
Munoz-Aceituno, Ester ;
Martos-Cabrera, Luisa ;
Carmen Ovejero-Benito, Maria ;
Reolid, Alejandra ;
Abad-Santos, Francisco ;
Dauden, Esteban .
MEDICINA-LITHUANIA, 2020, 56 (12) :1-15
[25]   The Effects of Pharmaceutical Excipients on Gastrointestinal Tract Metabolic Enzymes and Transporters-an Update [J].
Zhang, Wenpeng ;
Li, Yanyan ;
Zou, Peng ;
Wu, Man ;
Zhang, Zhenqing ;
Zhang, Tao .
AAPS JOURNAL, 2016, 18 (04) :830-843
[26]   Pharmacogenetics of irinotecan metabolism and transport: An update [J].
Smith, NF ;
Figg, WD ;
Sparreboom, A .
TOXICOLOGY IN VITRO, 2006, 20 (02) :163-175
[27]   An update on methotrexate pharmacogenetics in rheumatoid arthritis [J].
Ranganathan, Prabha .
PHARMACOGENOMICS, 2008, 9 (04) :439-451
[28]   Pharmacogenetics of drug transporters in modulating imatinib disposition and treatment outcomes in chronic myeloid leukemia and gastrointestinal stromal tumor patients [J].
Chen, Sylvia ;
Sutiman, Natalia ;
Chowbay, Balram .
PHARMACOGENOMICS, 2016, 17 (17) :1941-1955
[29]   Pharmacogenetics of tenofovir drug transporters in the context of HBV: Is there an impact? [J].
Cusato, J. ;
Manca, A. ;
Palermiti, A. ;
Mula, J. ;
Antonucci, M. ;
Chiara, F. ;
De Nicolo, A. ;
Lupia, Tommaso ;
Stroffolini, Giacomo ;
Boglione, L. ;
D'Avolio, A. .
BIOMEDICINE & PHARMACOTHERAPY, 2024, 175
[30]   Pharmacogenetics of irinotecan, doxorubicin and docetaxel transporters in Asian and Caucasian cancer patients: a comparative review [J].
Chen, Sylvia ;
Sutiman, Natalia ;
Zhang, Clara Zhenxian ;
Yu, Yingnan ;
Lam, Shirley ;
Khor, Chiea Chuen ;
Chowbay, Balram .
DRUG METABOLISM REVIEWS, 2016, 48 (04) :502-540